NACA1 inhibitors belong to a distinct chemical class of compounds characterized by their ability to selectively target and modulate the activity of N-acetyl-L-cysteine amide synthetase 1 (NACA1). NACA1 is an enzyme found in various tissues and cell types in the human body, playing a crucial role in cellular metabolism and redox homeostasis. These inhibitors are designed to specifically interact with NACA1 and interfere with its enzymatic function. The precise mechanism of action often varies among different NACA1 inhibitors, but their common objective is to regulate the production of N-acetyl-L-cysteine amide (NAC-amide), a metabolite generated by NACA1, which is implicated in various biochemical processes.
NACA1 inhibitors encompass a diverse array of compounds, ranging from small organic molecules to biologically derived agents. They can exhibit various structural and functional motifs, which are finely tuned to bind to NACA1's active site or allosteric regions, thereby impeding its catalytic activity. By modulating NACA1, these inhibitors can indirectly influence cellular processes associated with oxidative stress, reactive oxygen species (ROS) production, and sulfur metabolism. Consequently, NACA1 inhibitors hold promise as valuable tools for investigating the physiological roles of NAC-amide and the broader implications of NACA1 in cellular function. Further research into the specific mechanisms of NACA1 inhibition and their potential implications for various physiological pathways continues to be an area of active investigation in the field of chemical biology and biochemistry, shedding light on the intricate molecular interplay within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in the ribosome, indirectly affecting NACα's role in nascent polypeptide synthesis. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Blocks N-linked glycosylation, which can disrupt protein folding and thus indirectly affect NACα's associated processes. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA, potentially disrupting NACα function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits peptidyl transferase activity of the ribosome, thereby affecting protein synthesis and indirectly NACα's function. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Inhibits protein synthesis by blocking elongation at the ribosome, indirectly influencing NACα's role. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, indirectly affecting the transcription of mRNAs encoding for nascent polypeptides that NACα would interact with. | ||||||
Diphtheria Toxin, CRM Mutant | 92092-36-9 | sc-203924 | 0.25 mg | $639.00 | 1 | |
Inhibits protein synthesis by ADP-ribosylating elongation factor 2, indirectly affecting NACα's role. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Inhibits protein synthesis by blocking the peptidyl transferase reaction, potentially disrupting NACα's function. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Binds to the 50S ribosomal subunit and inhibits bacterial protein synthesis, which may indirectly influence NACα's role in eukaryotic cells. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Inhibits the turnover of elongation factor G (EF-G) from the ribosome, indirectly affecting protein synthesis and potentially NACα's function. | ||||||